在内分泌相关癌症中的激活:分子机制和翻译含义
Bruna Sousa Pessoa1, Nathalia Da Roz D'Alessandre2, Gabriela Der Agopian Guardia3
1Universidade de Sao Paulo Sao Paulo, SP Brazil.
Molecular cancer research : MCR
|February 24, 2026
概括
通过基因组不稳定性和表观遗传变化,LINE-1逆转移素驱动内分泌癌症. 它们的重新激活为甲状腺,上腺,垂体和前列腺瘤提供了潜在的生物标志物和治疗标.
科学领域:
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
- 在瘤学瘤学.
背景情况:
- 通过基因组不稳定性和表观遗传改变,LINE-1逆转移素与癌症的发展有关.
- 它们在与内分泌相关的癌症 (甲状腺,上腺,垂体,前列腺) 中的作用尽管观察到脱抑,但仍未得到充分研究.
研究的目的:
- 在内分泌瘤中合成LINE-1再激活的机械后果.
- 探索LINE-1生物学与荷尔蒙依赖性瘤行为之间的联系.
- 突出LINE-1生物学中的内分泌癌症转化机会.
主要方法:
- 关于LINE-1逆转移素在瘤发生过程中的现有文献的综述.
- 专注于LINE-1重新激活的机制及其对DNA损伤和信号通路的影响.
- 探索LINE-1编码蛋白 (ORF1p,ORF2p) 和它们的功能.
主要成果:
- LINE-1低甲基化和过度表达有助于DNA损伤,拷贝数变化和p53通路损伤.
- ORF1p可能共同调节核激素受体,将反元素与激素驱动的瘤联系起来.
- 在内分泌瘤中,ORF1p显示出作为表观遗传不稳定的生物标志物的潜力.
结论:
- LINE-1脱压是内分泌相关癌症的统一机制,具有重要的生物学和临床意义.
- 针对LINE-1逆转移素生命周期提出了治疗策略.
- ORF1p可以作为表观遗传不稳定的潜在替代生物标志物.
相关概念视频
Mitogens and the Cell Cycle
8.2K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
Endocrine Signaling
68.5K
Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
68.5K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
lncRNA - Long Non-coding RNAs
10.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
Metastasis
6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K

